Andrew Healy, MD
Neurological Surgery · Charlotte, NCNPI 1699949669
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 81.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $34,456 and has fallen 98.4% since, to $557 in 2025.
Across 216 payments — averaging $458.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$81K
- Stryker$16K
- Boston Scientific$521
- Johnson & Johnson$231
- Medtronic$218
- Orthofix Medical, Inc.$139
- plus $392 from 8 others
What the payments were for
- Royalty or licence$4991%
- Consulting fees$58,72559%
- Speaking & faculty fees$20,80021%
- Travel & lodging$14,14814%
- Food & beverage$4,8425%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 146 | $81,054 |
| Stryker | 21 | $16,459 |
| Boston Scientific | 14 | $521 |
| Johnson & Johnson(2 entities) | 7 | $231 |
| Medtronic(2 entities) | 8 | $218 |
| Orthofix Medical, Inc. | 10 | $139 |
| Bioventus LLC | 1 | $125 |
| Relievant Medsystems, Inc. | 1 | $116 |
| Abbott | 2 | $44 |
| Si-bone, Inc. | 2 | $38 |
| Theragen, Inc. | 1 | $20 |
| Intrinsic Therapeutics | 1 | $19 |
| CSL Behring | 1 | $19 |
| Baxter Healthcare | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TLIF$17,576
- XLIF$14,725
- Quartex$14,041
- NIAGARA LATERAL ACCESS SYSTEM$11,700
- RISE-L$9,118
- ALTERA$8,000
- RISE$4,280
- RAVINE LATERAL ACCESS SYSTEM$2,625
- CASCADIA INTERBODY SYSTEM$2,625
- TRITANIUM$1,703
- CREO$1,032
- COALITION$1,027
- Pulse$676
- CREO Deformity$354
- Intracept$232
- Excelsius3D Imaging System$155
- Traverse$152
- RELINE$136
- ALIF$136
- OsteoAMP$125
How this compares
$99,014 in reported general payments places this provider in the 85th percentile of 196 neurological surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 78 | $802 |
| Methocarbamol | 31 | $363 |
| Cyclobenzaprine Hcl | 24 | $322 |
| Tizanidine Hcl | 14 | $51 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Charlotte
- Domagoj CoricCharlotte$2.3M
- Paul KimCharlotte$1.5M
- Matthew McGirtCharlotte$693K
- Tim AdamsonCharlotte$470K
- Michael BohlCharlotte$120K
- Vincent RossiCharlotte$104K
- Joe BernardCharlotte$101K
- Anthony AsherCharlotte$93K
- Frederick FingerCharlotte$73K
- Joseph CheatleCharlotte$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.